AAMU
FLGT icon

Amundi Asset Management US’s Fulgent Genetics FLGT Stock Holding History

Amundi Asset Management US’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		$4.38M Buy
45,300
+11,300
+33% +$1.17M ﹤0.01% 1044
2020
Q4 		$1.77M Buy
+34,000
New +$1.42M ﹤0.01% 1144

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
NI
Nepsis Inc Minneapolis, Minnesota $295M AUM 35.44% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amundi Asset Management US's FLGT Position: Q1 2021 in Review

Amundi Asset Management US increased its Fulgent Genetics (FLGT) stake by 33% in Q1 2021, buying an estimated $1.17M and bringing the position to 45,300 shares worth $4.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1044.

Amundi Asset Management US first reported a position in FLGT in Q4 2020 and has held it in 2 quarters since. 256 funds tracked by Wall St. Rank hold FLGT as of Q1 2021.

  • Amundi Asset Management US held 45,300 shares of Fulgent Genetics worth $4.38M as of Q1 2021.
  • Amundi Asset Management US bought 11,300 Fulgent Genetics shares in Q1 2021, an estimated $1.17M.
  • Fulgent Genetics made up ﹤0.01% of Amundi Asset Management US's portfolio in Q1 2021, its #1044 holding.
  • Amundi Asset Management US first reported a position in Fulgent Genetics in Q4 2020 and has held it in 2 quarters since.
  • 256 funds tracked by Wall St. Rank held Fulgent Genetics as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.